Sign up online today & collaborate
or click here to find out more
Farnham, UK – How can development teams determine the future value of an asset, with phase 3 data years away? Answering that question requires evaluation of three distinct sources of value: clinical, patient and commercial. Though some consider these value streams independently, the only way to understand how they interact with, and amplify, each other is to review them collectively. Our recommendations on defining the three sources of value, and evaluating them can be found here.